The Pershing Square Sohn Prize for Young Investigators in Cancer Research provides young, greater New York area-based scientists the freedom to take risks and pursue their boldest research at a stage when traditional funding is lacking. In the quest for cures, the Prize accelerates the collaboration between academia and industry. Prize winners each receive $200,000 a year for up to three years.
Innovative research: Truly novel approaches in cancer research with strong scientific rationale. Early stage and bold proposals are encouraged and will receive special consideration. The research areas include but are not limited to technology development and basic biology. The objective is to support projects that may be too innovative and speculative for traditional funding sources but still have a likelihood of producing important findings. It should be a unique project for scientists, who are encouraged to stretch their imagination into areas that can substantially change the area of research.
Scientific excellence: Scientific merit as determined by the Pershing Square Sohn Prize Scientific Advisory Council and the Prize Advisory Board.
Application to cancer: Proposals that articulate a clearly defined application to cancer will be favored. Goal is to advance research in new ways that will have an impact on understanding, diagnosis, prevention and/or treatment of cancer.
An MD, PhD, MD-PhD degree (or equivalent) is required. Applicants must have at least two (2) years of experience running their own laboratories but no more than eight (8) years of experience by the anticipated start date of the research project (July 2019). Principal Investigators (PIs) must hold faculty appointments at academic research institutions in the greater New York City area at the level of Assistant or Associate Professor (or equivalent). The greater New York City area includes New York City’s five boroughs, Long Island, Westchester County, New Jersey, and New Haven County in Connecticut.
An applicant who is not a U.S. citizen or permanent resident, by submitting an application for this funding, assures that his/her visa status will provide sufficient time to complete the project and grant term within the United States. Investigators need not be specifically trained in cancer research; however, they should be working in an environment capable of conducting high quality, high impact cancer research.
The application portal for the 2020 Pershing Square Sohn Prize for Young Investigators in Cancer Research is not yet open.
Our 2019 application cycle has ended and the application system is now closed.
The system will reopen on September 30, 2019 to accept Letters of Intent for the 2020 Pershing Square Sohn Prize for Young Investigators in Cancer Research. The deadline to submit a Letter of Intent is November 4, 2019 at 5:00pm EST.
Upon review, selected applicants will be invited to submit a Full-Length Proposal. Applicants will be notified about the status of their application no later than December 19, 2019.
Please be sure to thoroughly read the above application guidelines before starting your application.
If you have any questions regarding the Prize, please contact us at firstname.lastname@example.org.
Visit: www.psscra.org to learn more about the Alliance.